Cancer immunotherapeutics work by unleashing the power of a patient’s immune system to fight cancer and have emerged as one of the most exciting new approaches to cancer treatment. As of July 31, 2023, at least 23 different cancer immunotherapeutics have been approved by the FDA.
Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy - ScienceDirect
AACR Cancer Progress Report
Looking to the Future of Cancer Science and Medicine
Ramping Up the Fight - Georgia Trend Magazine
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR)
Advancing Cancer Science and Medicine
Why immunotherapy is the next frontier for treating disease
Advancing Cancer Science and Medicine
Understanding How Cancer Develops